Archive ready

2025年3月期 決算短信〔日本基準〕(連結)

https://www.cawachi.co.jp/wp/wp-content/uploads/ir-tan20250424.pdf
May 13, 2026 at 12:35 AM JSTThe archive page, viewer, and downloads use this saved version.
May 13, 2026 at 12:35 AM JST·www.cawachi.co.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved PDF

2025年3月期 決算短信〔日本基準〕(連結)

StartedMay 13, 2026 at 12:35 AM JST
File size0.29 MB
SHA-256d0be2fd81e0c53ae769096bedc16dfd44baab3b9e7275d8909798b9302b04fd2
About this pageAI generated

This document presents the financial results for the fiscal year ending March 2025 of Kawachi Drugstore Co., Ltd. The sales for the fiscal year reached 287,816 million yen, reflecting a 0.6% increase compared to the previous year. However, operating profit decreased by 1.8% to 7,461 million yen, and ordinary profit fell by 3.1% to 8,340 million yen. The net profit attributable to shareholders was 4,884 million yen, marking a 3.6% increase. Despite a gradual economic recovery, challenges such as rising prices and intensified competition persist. The company declared a dividend of 80 yen, with a payout ratio of 36.6%. Future projections for the fiscal year ending March 2026 estimate sales at 292,000 million yen.